NCT00069901 - Phase II CT-2103/Carboplatin in Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

November 30, 2005

Study Completion Date

September 30, 2006

Conditions

Ovarian Neoplasm

Interventions

DRUG

CT-2103 (poly(L)glutamate-paclitaxel)

DRUG

carboplatin

Trial Locations (17)

18840

Guthrie Foundation for Education and Research, Sayre

19141

Albert Einstein Cancer Center, Philadelphia

22205

Arlington Fairfax Hematology Oncology, Arlington

29203

South Carolina Oncology Assoicates, Columbia

33143

Raben and Fldman Research Associates, South Miami

37403

Chattanooga GYN-Oncology, Chattanooga

37920

Baptist Regional Cancer Center, Knoxville

40202

University of Louisville, Louisville

43222

Gynecology, Oncology, and Pelvic Surgery Associates, Inc., Columbus

53201

Aurora Health Care, Inc., Milwaukee

64132

Resource Center for Gynecology/ Oncology, Kansas City

94904

California Cancer Care, Greenbrae

95204

Stockton Hematology Oncology Medical, Stockton

98104

Upstate New York Cancer Research and Education Foundation, Rochester

Pacific Gynecology Specialists, Seattle

Swedish Cancer Institute, Seattle

Unknown

Gynecology Oncology Associates, Greenbrae